Metropolis Healthcare cashes in on rich valuation to acquire Core Diagnostics
Source: Live Mint Metropolis Healthcare Ltd has chosen the inorganic route to climb the value chain in pathology by acquiring a 100% stake in Core Diagnostics, a specialist in oncology (cancer) testing. The impressive part is that it also helps Metropolis cash in on its rich valuation, as 45% of the payment will be funded…